3.0.0 2117 2023-01-11T15:48:00Z 2023-01-11T15:48:00Z House H HR 2007-05-02 110 hsif00 Energy and Commerce Committee House Standing hsif17 Innovation, Data, and Commerce Subcommittee Referred to 2007-05-02T16:40:11Z hsif14 Health Subcommittee Referred to 2007-05-02T16:40:00Z Referred to 2007-05-02T14:00:15Z 2007-05-02 hsif17 Innovation, Data, and Commerce Subcommittee 1 House committee actions Referred to the Subcommittee on Commerce, Trade and Consumer Protection. Committee 2007-05-02 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2007-05-02 Referred to the House Committee on Energy and Commerce. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2007-05-02 Sponsor introductory remarks on measure. (CR E925) IntroReferral B00100 9 Library of Congress 2007-05-02 Introduced in House IntroReferral Intro-H 9 Library of Congress 2007-05-02 Introduced in House IntroReferral 1000 9 Library of Congress P000583 Rep. Paul, Ron [R-TX-14] RON PAUL R TX 14 N B001149 Rep. Burton, Dan [R-IN-5] DAN BURTON R IN 5 2007-05-02 True S001144 Rep. Shays, Christopher [R-CT-4] CHRISTOPHER SHAYS R CT 4 2007-05-02 True B000208 Rep. Bartlett, Roscoe G. [R-MD-6] ROSCOE BARTLETT R MD G. 6 2007-05-02 True D000533 Rep. Duncan, John J., Jr. [R-TN-2] JOHN DUNCAN R TN J. 2 2007-05-02 True F000452 Resident Commissioner Fortuno, Luis G. [R-PR-At Large] Luis Fortuno R PR G. 0 2007-06-08 False D000191 Rep. DeFazio, Peter A. [D-OR-4] PETER DEFAZIO D OR A. 4 2007-06-08 False K000364 Rep. Kuhl, John R. "Randy", Jr. [R-NY-29] John Kuhl R NY R. "Randy" 29 2007-06-15 False M001152 Rep. Musgrave, Marilyn N. [R-CO-4] Marilyn Musgrave R CO N. 4 2007-08-03 False R000409 Rep. Rohrabacher, Dana [R-CA-46] DANA ROHRABACHER R CA 46 2007-12-18 False Agriculture and Food Administrative procedure Administrative remedies Arthritis Bone fractures Calcium Cardiovascular diseases Commerce Communication in medicine Communication in science Conflict of interests Deceptive advertising Department of Health and Human Services Dietary supplements Drug advertising Evidence (Law) Federal Trade Commission Federal advisory bodies Government Operations and Politics Government publications Governmental investigations Health Independent regulatory commissions Labeling Law Medicinal plants Nutrition Oils and fats Periodicals Preventive medicine Science, Technology, Communications Agriculture and Food 00 2007-05-02 Introduced in House 2007-06-14T21:26:11Z Health Freedom Protection Act - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to provide that a food or dietary supplement is not a drug solely because the label or labeling contains a claim to cure, mitigate, treat, or prevent disease.

Prohibits the Secretary of Health and Human Services from: (1) restricting the reprinting and distribution or sale of any U.S. government publication or any accurate quotations of such a publication, including content concerning nutrients and disease treatment or prevention; or (2) construing the distribution or sale of, or accurate quotation from, such a publication in connection with the sale of a food or dietary supplement as evidence of an intent to sell that food or dietary supplement as a drug.

Requires the Secretary to allow claims on food or nutrient labeling that characterize the relationship of a nutrient to the cure, mitigation, treatment, or prevention of a disease (with no more than a three-sentence disclaimer) unless the Secretary proves by clear and convincing evidence that: (1) there is no scientific evidence that supports the claim; and (2) the claim is inherently misleading and incapable of being rendered nonmisleading through the addition of a disclaimer.

Authorizes the use of specified health claims on the label of all foods and dietary supplements, including claims related to saw palmetto, omega-3 fatty acids, glucosamine, and calcium.

Allows a statement for a dietary supplement to include words that are recognized as signs or symptoms of disease so long as the statement does not include the name of a specific disease.

Amends the Federal Trade Commission Act to exempt from being regulated as advertising: (1) government publications exempted from reprinting or distribution restrictions under FFDCA; or (2) accurate summaries of scientific publications. Places the burden of proof that an advertisement for a dietary supplement or ingredient is false and misleading on the Federal Trade Commission.

]]> Health Freedom Protection Act Display Title Health Freedom Protection Act Official Title as Introduced To amend the Federal Food, Drug, and Cosmetic Act concerning foods and dietary supplements, to amend the Federal Trade Commission Act concerning the burden of proof in false advertising cases, and for other purposes. Introduced in House IH Short Titles as Introduced Health Freedom Protection Act Introduced in House 2007-05-02T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-110hr2117ih/xml/BILLS-110hr2117ih.xml 2007-05-02 Referred to the Subcommittee on Commerce, Trade and Consumer Protection. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.